Botswana

9 Vaccines Approved for Use in Botswana

RNA

Moderna

Spikevax

Approved in 88 countries
70 trials in 24 countries
Approval Source: reuters.com
RNA

Pfizer/BioNTech

Comirnaty

Approved in 149 countries
100 trials in 31 countries
Approval Source: xinhuanet.com
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Approval Source: bomra.co.bw
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 149 countries
73 trials in 34 countries
Approval Source: xinhuanet.com
Non Replicating Viral Vector

Serum Institute of India

Covishield (Oxford/ AstraZeneca formulation)

Approved in 49 countries
6 trials in 1 country
Approval Source: xinhuanet.com
Inactivated

Bharat Biotech

Covaxin

Approved in 14 countries
16 trials in 2 countries
Approval Source: bomra.co.bw
Inactivated

Sinovac

CoronaVac

Approved in 56 countries
42 trials in 10 countries
Approval Source: bomra.co.bw
Protein Subunit

Biological E Limited

Corbevax

Approved in 2 countries
7 trials in 1 country
Approval Source: bnnbloomberg.ca
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Jcovden

Approved in 113 countries
26 trials in 25 countries
Approval Source: bomra.co.bw

1 in Clinical Trials in Botswana

RNA

Moderna

Spikevax

Approved in 88 countries
70 trials in 24 countries